Learn More
Medchemexpress LLC Elraglusib | 1034895-42-5 | ≥98.0% | 404.35 g/mol | C22H13FN2O5 | 5 MG

Supplier: Medchemexpress LLC HY1139145MG
9-ING-41 (Elraglusib) is a maleimide-based, ATP-competitive selective inhibitor of glycogen synthase kinase-3β (GSK-3β) used in preclinical research to study signaling pathways, apoptosis, autophagy, and antitumor activity. It is provided as a small-molecule powder for laboratory use.
- Selective GSK-3β inhibitor with reported IC50 of 0.71 μM.
- Induces cell cycle arrest, apoptosis, and autophagy in cancer cells.
- Suitable for in vitro and in vivo research as a small-molecule powder.
- Molecular formula C22H13FN2O5; molecular weight 404.35 g/mol.
- Recommended storage: powder at -20°C for long-term stability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.